NATURE’S SUNSHINE PRODUCTS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2023-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $2.90M, a 22.25% decline from fiscal 2021.
- NATURE’S SUNSHINE PRODUCTS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $3.73M, a 1.48% decline from fiscal 2020.
- NATURE’S SUNSHINE PRODUCTS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $3.79M, a 78.63% increase from fiscal 2019.
- NATURE’S SUNSHINE PRODUCTS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was $2.12M, a 2.30% decline from fiscal 2018.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|
| 2022-12-31 | $2.90M 10-K · filed 2023-03-16 |
| 2021-12-31 | $3.73M 10-K · filed 2023-03-16 |
| 2020-12-31 | $3.79M 10-K · filed 2022-03-08 |
| 2019-12-31 | $2.12M 10-K · filed 2021-03-10 |
| 2018-12-31 | $2.17M 10-K · filed 2020-03-11 |
| 2017-12-31 | $2.22M 10-K · filed 2019-03-08 |
| 2016-12-31 | $3.22M 10-K · filed 2019-03-08 |
| 2015-12-31 | $4.49M 10-K · filed 2018-03-16 |
| 2014-12-31 | $3.95M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |